FAKTOR OPTIONSSCHEIN - BIOGEN IDEC | Market Closed - Bid/Ask 02:58:58 2024-06-03 pm EDT | Pre-market 02:30:01 am | |||
| 1.84 EUR | -27.84% |
|
1.94 | +5.43% |
| Current month | -27.84% | ||
| 1 month | -61.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-03 | 1.84 | -27.84% |
| 24-05-31 | 2.55 | -23.42% |
| 24-05-30 | 3.33 | -22.56% |
| 24-05-29 | 4.3 | +17.81% |
| 24-05-28 | 3.65 | -2.67% |
Delayed Quote Börse Stuttgart
Last update June 03, 2024 at 02:58 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD462X |
| ISIN | DE000HD462X3 |
| Date issued | 2024-03-27 |
| Strike | 252.8 $ |
| Maturity | Unlimited |
| Parity | 13.41 : 1 |
| Emission price | 9.8 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 26.49 € |
|---|---|
| Lowest since issue | 1.82 € |
| Spread | 0.02 € |
| Spread % | 1.04% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
229.8
USD
Average target price
284.8
USD
Spread / Average Target
+23.93%
- Stock Market
- Certificates
- Certificat
